US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Bone Biologics Corporation (BBLG)
Bone Biologics Corporation (BBLG) ニュース

BBLG

Bone Biologics (BBLG)

Bone Biologics Corporation

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:BBLG

1 2 3 4 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/03/07	06 : 15	Business Wire	Bone Biologics Announces Closing of $2.0 Million Public Offering	NASDAQ:BBLG	Bone Biologics Corporation
2024/03/05	14 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:BBLG	Bone Biologics Corporation
2024/03/05	07 : 21	Edgar (US Regulatory)	Form 424B4 - Prospectus [Rule 424(b)(4)]	NASDAQ:BBLG	Bone Biologics Corporation
2024/03/04	23 : 15	Business Wire	Bone Biologics Announces Pricing of $2.0 Million Public Offering	NASDAQ:BBLG	Bone Biologics Corporation
2024/03/01	22 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BBLG	Bone Biologics Corporation
2024/03/01	22 : 00	Business Wire	Bone Biologics Reports Progress With NB1 Clinical Program	NASDAQ:BBLG	Bone Biologics Corporation
2024/02/27	06 : 50	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:BBLG	Bone Biologics Corporation
2024/02/24	07 : 09	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:BBLG	Bone Biologics Corporation
2024/02/22	07 : 05	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:BBLG	Bone Biologics Corporation
2024/02/15	08 : 41	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:BBLG	Bone Biologics Corporation
2024/02/15	00 : 55	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:BBLG	Bone Biologics Corporation
2024/02/14	10 : 03	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:BBLG	Bone Biologics Corporation
2024/01/31	07 : 09	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:BBLG	Bone Biologics Corporation
2024/01/25	14 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:BBLG	Bone Biologics Corporation
2024/01/20	07 : 24	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BBLG	Bone Biologics Corporation
2024/01/20	07 : 22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BBLG	Bone Biologics Corporation
2024/01/18	07 : 21	Edgar (US Regulatory)	Form S-3/A - Registration statement under Securities Act of 1933: [Amend]	NASDAQ:BBLG	Bone Biologics Corporation
2024/01/13	07 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BBLG	Bone Biologics Corporation
2024/01/11	22 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BBLG	Bone Biologics Corporation
2024/01/11	22 : 00	Business Wire	Bone Biologics Appoints Healthcare Finance Veteran Robert E. Gagnon to Board of Directors	NASDAQ:BBLG	Bone Biologics Corporation
2024/01/11	07 : 17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BBLG	Bone Biologics Corporation
2024/01/11	07 : 15	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:BBLG	Bone Biologics Corporation
2024/01/10	22 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BBLG	Bone Biologics Corporation
2024/01/10	22 : 00	Business Wire	Bone Biologics Regains Compliance with Nasdaq Continued Listing Requirements	NASDAQ:BBLG	Bone Biologics Corporation
2024/01/06	07 : 15	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:BBLG	Bone Biologics Corporation
2024/01/03	07 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BBLG	Bone Biologics Corporation
2024/01/03	05 : 34	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:BBLG	Bone Biologics Corporation
2023/12/21	07 : 21	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:BBLG	Bone Biologics Corporation
2023/12/18	22 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BBLG	Bone Biologics Corporation
2023/12/18	22 : 00	Business Wire	Bone Biologics Announces 1-for-8 Reverse Stock Split	NASDAQ:BBLG	Bone Biologics Corporation

Showing the most relevant articles for your search:NASDAQ:BBLG

1 2 3 4 次へ >>

Insured Finance

Vontobel Financial Produ...

Intsanpaolo Tv Eur3m+4,1...

Ftp Dividend Strength Po...

Mobiv Acquisition

Horizon Technology Finance

Auto Italia (PK)

MetaSoccer Universe

Goldman Sachs Emerging M...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約